Form 4 holding
Chief Medical Officer
Larimar Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 71,443
- Estimated value
- $272,197
- Report date
- 26 Jan 2026
- Price
- $3.81
- Ownership
- Direct
Russell Clayton - Chief Medical Officer at Larimar Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- LRMR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Russell Clayton since 21 Sep 2025
Reported holdings for Russell Clayton in Larimar Therapeutics, Inc.
Form 4 holding
Chief Medical Officer
Larimar Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 153,822
- Estimated value
- Report date
- 26 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Russell Clayton in Larimar Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.